PPCB ▲ +177.6% - Propanc Biopharma, Inc. $PPCB Propanc Biopharma Announces Compelling New Preclinical Pancreatic Cancer Data for PRP Showing >90% Tumor Growth Inhibition and >2.5-Fold Survival Benefit 27-AUG-2026 08:31 AM ET